The Biden Administration is invoking the Defense Production Act (DPA) to increase manufacturing of existing vaccines, a move that could help expand limited supplies and get more vaccinations sites up and running.
But the idea that any company, even another pharmaceutical company, can simply start producing the vaccines is easier than it sounds, according to some experts.
“One of the delusions I think people have is the idea that the Defense Production Act … you can’t do that with…
Source link
